[1] 郑树国,董家鸿,黄志强,等.肝门部胆管癌外科20年经验回顾
[J].中国普通外科杂志,2001, 10 (1):6-10.
[2] Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: Results of a prospective study
[J].Ann Surg,2004,240(1):95-101.
[3] (此文献文题请核实) Zervous EE, Pearson H, Durkin AJ, et al. ln continuity hepaticresection for advanced hilar cholangiocarcinoma
[J]. Am J Surg, 2004,188:584-588.
[4] 马幼平,李恩山,陈孝平,等.肝门部胆管癌的诊治:附96例报告
[J].中国普通外科杂志,2008,
17 (8): 798-800.
[5] 梁力建,赖佳明,李绍强,等.103例肝门部胆管癌的外科手术切除治疗
[J],中华外科杂志,2006, 44 (13): 882-884.
[6] 何晓东,康维明.恶性梗阻性黄疽的术前胆道引流与Ⅱ期手术
[J].中国医刊, 2002, 37(12):14-16.
[7] Seyama Y, Kubota K, Sano K,et al. Long-term out-come of extended hemihepatectomy for hilar bile ductcancer with no mortality and high survival rate
[J].Ann Surg,2003,238(1):73-83.
[8] 张永杰.肝门部胆管癌可切除性的术中判断技巧
[J].中国实用外科杂志,2007, 27(1):93-95.
[9] Nagino M,Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilarmalignancy: preoperative blood donation, blood loss, transfusion, and out-come
[J]. Surgery, 2005, 137(2):148-155.
[10] Nishio H, Nagino M, Oda K, et al. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system
[J].Langenbecks Arch Surg, 2005, 390 (4):319-327.
[11] 曲辉,赵平,单毅. 肝门部胆管癌外科治疗进展
[J].临床外科杂志,2004,16(4):273-274.